SINOPHARM (01099): China National Medical Device's operating profit for the first three quarters was RMB 856 million, down 11.07% year on year.
Sinopharm Group (01099) announced that its subsidiary China National Medical Device Co., Ltd. (Sinopharm Devices) achieved operating revenue of RMB 55.262 billion for the nine months ended September 30, 2026, up 1.04% year on year; operating profit was RMB 856 million, down 11.07% year on year; total comprehensive income attributable to owners of the parent was RMB 391 million, down 1.03% year on year.
SINOPHARM (01099) announced that its subsidiary China National Medical Device Co., Ltd. (Sinopharm Devices) achieved operating revenue of RMB 55.262 billion for the nine months ended September 30, 2026, up 1.04% year on year; operating profit was RMB 856 million, down 11.07% year on year; total comprehensive income attributable to owners of the parent was RMB 391 million, down 1.03% year on year.
Related Articles
Fuel costs surge 69%, eroding profit margins: Union Pacific (UNP.US) Q3 revenue hits record but fails to mask cost concerns.
TUHU-W (09690) repurchased 355,000 shares on October 22 for HK$3.9895 million.
CDB LEASING (01606) intends to purchase information technology computer equipment for RMB 1.5 billion.
Fuel costs surge 69%, eroding profit margins: Union Pacific (UNP.US) Q3 revenue hits record but fails to mask cost concerns.
TUHU-W (09690) repurchased 355,000 shares on October 22 for HK$3.9895 million.
CDB LEASING (01606) intends to purchase information technology computer equipment for RMB 1.5 billion.
